9-133579136-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080515.3(FAM163B):āc.387G>Cā(p.Glu129Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,609,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001080515.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM163B | NM_001080515.3 | c.387G>C | p.Glu129Asp | missense_variant | 3/3 | ENST00000673969.1 | NP_001073984.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM163B | ENST00000673969.1 | c.387G>C | p.Glu129Asp | missense_variant | 3/3 | NM_001080515.3 | ENSP00000501259 | P1 | ||
FAM163B | ENST00000496132.2 | c.387G>C | p.Glu129Asp | missense_variant | 3/3 | 3 | ENSP00000419867 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000258 AC: 6AN: 232334Hom.: 0 AF XY: 0.0000156 AC XY: 2AN XY: 128416
GnomAD4 exome AF: 0.00000961 AC: 14AN: 1457236Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 725060
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2022 | The c.387G>C (p.E129D) alteration is located in exon 2 (coding exon 2) of the FAM163B gene. This alteration results from a G to C substitution at nucleotide position 387, causing the glutamic acid (E) at amino acid position 129 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at